Skip to main content
. 2023 Jun 25;24(13):10622. doi: 10.3390/ijms241310622

Figure 2.

Figure 2

MicroRNA expression at baseline (B) presented in the (A) and post-chemotherapy (PC) presented in the (B), regardless of the therapy regimen administered in non-responder (NR) vs. responder (R) patients. The fold change for each sample was calculated relative to the PR group. * p ≤ 0.05.